Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 1
1973 1
1974 1
1975 1
1977 1
1982 1
1989 1
1995 1
1996 1
1998 1
2000 3
2001 1
2002 1
2003 6
2004 1
2005 1
2009 2
2010 1
2011 2
2012 2
2013 2
2014 1
2015 1
2016 5
2017 3
2018 4
2019 5
2020 10
2021 9
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies.
Ortíz-Maldonado V, Rives S, Castellà M, Alonso-Saladrigues A, Benítez-Ribas D, Caballero-Baños M, Baumann T, Cid J, Garcia-Rey E, Llanos C, Torrebadell M, Villamor N, Giné E, Díaz-Beyá M, Guardia L, Montoro M, Català A, Faura A, González EA, Español-Rego M, Klein-González N, Alsina L, Castro P, Jordan I, Fernández S, Ramos F, Suñé G, Perpiñá U, Canals JM, Lozano M, Trias E, Scalise A, Varea S, Sáez-Peñataro J, Torres F, Calvo G, Esteve J, Urbano-Ispizua Á, Juan M, Delgado J. Ortíz-Maldonado V, et al. Among authors: trias e. Mol Ther. 2021 Feb 3;29(2):636-644. doi: 10.1016/j.ymthe.2020.09.027. Epub 2020 Sep 20. Mol Ther. 2021. PMID: 33010231 Free PMC article. Clinical Trial.
Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis.
de Oliveira LMG, Carreira RB, de Oliveira JVR, do Nascimento RP, Dos Santos Souza C, Trias E, da Silva VDA, Costa SL. de Oliveira LMG, et al. Among authors: trias e. Neurotox Res. 2023 Jun;41(3):288-309. doi: 10.1007/s12640-022-00632-1. Epub 2023 Feb 17. Neurotox Res. 2023. PMID: 36800114 Review.
Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial.
Castella M, Caballero-Baños M, Ortiz-Maldonado V, González-Navarro EA, Suñé G, Antoñana-Vidósola A, Boronat A, Marzal B, Millán L, Martín-Antonio B, Cid J, Lozano M, García E, Tabera J, Trias E, Perpiña U, Canals JM, Baumann T, Benítez-Ribas D, Campo E, Yagüe J, Urbano-Ispizua Á, Rives S, Delgado J, Juan M. Castella M, et al. Among authors: trias e. Front Immunol. 2020 Mar 20;11:482. doi: 10.3389/fimmu.2020.00482. eCollection 2020. Front Immunol. 2020. PMID: 32528460 Free PMC article. Clinical Trial.
Regulatory issues in cell-based therapy for clinical purposes.
Casaroli-Marano RP, Tabera J, Vilarrodona A, Trias E. Casaroli-Marano RP, et al. Among authors: trias e. Dev Ophthalmol. 2014;53:189-200. doi: 10.1159/000357766. Epub 2014 Apr 10. Dev Ophthalmol. 2014. PMID: 24732772 Review.
PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease.
Duhalde Vega M, Olivera D, Gastão Davanzo G, Bertullo M, Noya V, Fabiano de Souza G, Primon Muraro S, Castro I, Arévalo AP, Crispo M, Galliussi G, Russo S, Charbonnier D, Rammauro F, Jeldres M, Alamón C, Varela V, Batthyany C, Bollati-Fogolín M, Oppezzo P, Pritsch O, Proença-Módena JL, Nakaya HI, Trias E, Barbeito L, Anegon I, Cuturi MC, Moraes-Vieira P, Segovia M, Hill M. Duhalde Vega M, et al. Among authors: trias e. Sci Adv. 2022 Sep 23;8(38):eabn6545. doi: 10.1126/sciadv.abn6545. Epub 2022 Sep 21. Sci Adv. 2022. PMID: 36129987 Free PMC article.
72 results